logo

For the Inventor, By the Inventor

Edgewater, NJ, United States of America

Phil Skolnick

This inventor holds 8 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Neurovance, Inc., Dov Pharmaceutical, Inc., Euthymics Bioscience, Inc.. Active years: 2012-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Phil Skolnick. Retrieved from https://idiyas.com/inventor/phil-skolnick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 62.5

 

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 42(Granted Patents)


Company Filing History:

goldMedal4 out of 7 
 
Neurovance, Inc.
 patents
silverMedal2 out of 8 
 
Dov Pharmaceutical, Inc.
 patents
bronzeMedal1 out of 6 
 
Euthymics Bioscience, Inc.
 patents
4. 1 out of 19 
 
Otsuka America Pharmaceutical, Inc.
 patents

Years Active: 2012-2018

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 10039746 - 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders (2018-08-07),
2. 9737506 - 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders (2017-08-22),
3. 9597315 - 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments (2017-03-21),
4. 9205074 - 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders (2015-12-08),
5. 9133159 - 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments (2015-09-15),
6. 8877798 - 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders (2014-11-04),
7. 8461196 - 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders (2013-06-11),
8. 8138377 - Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use (2012-03-20),

Title: Phil Skolnick: Innovator in Neuropsychiatric Treatments

Introduction

Phil Skolnick is a prominent inventor based in Edgewater, NJ (US), known for his significant contributions to the field of neuropsychiatric disorders. With a total of 8 patents to his name, Skolnick has made remarkable strides in developing innovative treatments aimed at improving mental health.

Latest Patents

Among his latest patents is the invention of novel, multiply-substituted 1-aryl-3-azabicyclo[3.1.0]hexanes. This invention focuses on the preparation and use of these compounds to treat and prevent central nervous system (CNS) disorders, including depression and anxiety. The related processes and intermediates for preparing these compounds are crucial for advancing therapeutic options in mental health care.

Career Highlights

Throughout his career, Phil Skolnick has worked with notable companies such as Neurovance, Inc. and Dov Pharmaceutical, Inc. His work has been instrumental in the development of new medications that address complex neuropsychiatric conditions.

Collaborations

Skolnick has collaborated with esteemed colleagues, including Zhengming Chen and Anthony Basile, to further enhance the impact of his research and innovations in the field.

Conclusion

Phil Skolnick's contributions to neuropsychiatric treatment through his patents and collaborations highlight his dedication to improving mental health care. His innovative approaches continue to pave the way for advancements in the treatment of CNS disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…